881 related articles for article (PubMed ID: 19495780)
21. Primary large B-cell lymphoma of the bone marrow.
Hishizawa M; Okamoto K; Chonabayashi K; Kaneko H; Watanabe M; Tsudo M
Br J Haematol; 2007 Feb; 136(3):351. PubMed ID: 17233843
[No Abstract] [Full Text] [Related]
22. Primary cutaneous large B-cell lymphoma, leg type, successfully treated with rituximab plus chemotherapy.
Posada García C; Florez A; Pardavila R; Garcia-Cruz A; Amador L; Alvarez M; Alberte LM; Cruces MJ
Eur J Dermatol; 2009; 19(4):394-5. PubMed ID: 19467966
[No Abstract] [Full Text] [Related]
23. Primary non-Hodgkin's lymphoma of the uterus, cervix and parametrium treated by combined immunochemotherapy.
Su CF; Tsai HJ; Kuo C; Chen GD; Lin LY; Huang CC; Luo KH
J Obstet Gynaecol Res; 2008 Aug; 34(4 Pt 2):749-53. PubMed ID: 18840196
[TBL] [Abstract][Full Text] [Related]
24. Serum BAFF predicts prognosis better than APRIL in diffuse large B-cell lymphoma patients treated with rituximab plus CHOP chemotherapy.
Kim SJ; Lee SJ; Choi IY; Park Y; Choi CW; Kim IS; Yu W; Hwang HS; Kim BS
Eur J Haematol; 2008 Sep; 81(3):177-84. PubMed ID: 18510703
[TBL] [Abstract][Full Text] [Related]
25. Intravascular B-cell lymphoma: the role of skin biopsy.
Barnett CR; Seo S; Husain S; Grossman ME
Am J Dermatopathol; 2008 Jun; 30(3):295-9. PubMed ID: 18496438
[TBL] [Abstract][Full Text] [Related]
26. Non-multiple lymphomatous polyposis form of mantle cell lymphoma in the gastrointestinal tract.
Tamura S; Ohkawauchi K; Yokoyama Y; Higashidani Y; Daibata M; Hiroi M; Yamamori S; Onishi S
J Gastroenterol; 2004 Oct; 39(10):995-1000. PubMed ID: 15549454
[TBL] [Abstract][Full Text] [Related]
27. Cutaneous plasmablastic lymphoma.
Jambusaria A; Shafer D; Wu H; Al-Saleem T; Perlis C
J Am Acad Dermatol; 2008 Apr; 58(4):676-8. PubMed ID: 18342714
[TBL] [Abstract][Full Text] [Related]
28. Primary cutaneous diffuse large B cell lymphoma, leg type.
Dongre A; Kar S; Gondse S; Gangane N; Mehra BK
Indian J Dermatol Venereol Leprol; 2011; 77(2):212-4. PubMed ID: 21393962
[No Abstract] [Full Text] [Related]
29. [Relationship between clinopathological features and outcome of rituximab treatment for diffuse large B-cell lymphoma].
Zhang HY; Guan ZZ; Wang B; Huang HQ; Xia ZJ; Lin TY
Zhonghua Zhong Liu Za Zhi; 2008 May; 30(5):381-4. PubMed ID: 18953841
[TBL] [Abstract][Full Text] [Related]
30. Aggressive lymphoma involving intracranial epidural region.
Villela LM; Blanco-Salazar A; Caballero R; Borbolla-Escoboza R
J Neurooncol; 2007 Jun; 83(2):181-2. PubMed ID: 17332949
[No Abstract] [Full Text] [Related]
31. Partial remission of a newly diagnosed diffuse large B-cell Non-Hodgkin's lymphoma in a hemodialysis patient after administration of immuno-chemotherapy with rituximab-CHOP.
Feldmann G; Nattermann J; Gerhardt T; Nähle CP; Spengler U; Woitas R
Int J Lab Hematol; 2007 Dec; 29(6):469-73. PubMed ID: 17988304
[TBL] [Abstract][Full Text] [Related]
32. Impressive response to temsirolimus in a patient with chemotherapy refractory diffuse large B-cell non-Hodgkin's lymphoma.
Kiewe P; Thiel E
Ann Hematol; 2011 Jan; 90(1):109-10. PubMed ID: 20387065
[No Abstract] [Full Text] [Related]
33. [Lymphoproliferative disease following kidney transplantation].
Merkle M; Rupprecht HD
Dtsch Med Wochenschr; 2005 Jul; 130(28-29):1691-4. PubMed ID: 16003604
[TBL] [Abstract][Full Text] [Related]
34. Estimating the impact of rituximab on bcl-2-associated resistance to CHOP in elderly patients with diffuse large B-cell lymphoma.
Mounier N; Briere J; Gisselbrecht C; Reyes F; Gaulard P; Coiffier B;
Haematologica; 2006 May; 91(5):715-6. PubMed ID: 16670080
[TBL] [Abstract][Full Text] [Related]
35. [Treatment options in non-Hodgkin lymphomas].
Tilly H
Rev Prat; 2010 Jan; 60(1):69-74. PubMed ID: 20222315
[TBL] [Abstract][Full Text] [Related]
36. Composite T lymphoblastic leukemia/lymphoma and diffuse large B-cell lymphoma: case report.
Niino D; Ohsaki K; Arakawa F; Watanabe J; Kimura Y; Kiyasu J; Takeuchi M; Miyoshi H; Yoshida M; Sugita Y; Ohshima K; Okamura T
Pathol Int; 2011 Jun; 61(6):363-8. PubMed ID: 21615612
[TBL] [Abstract][Full Text] [Related]
37. Reversible posterior leukoencephalopathy syndrome following R-CHOP therapy for diffuse large B-cell lymphoma.
Hosoi M; Yamamoto G; Imai Y; Kurokawa M
Ann Hematol; 2010 Feb; 89(2):207-8. PubMed ID: 19582454
[No Abstract] [Full Text] [Related]
38. [A three-year experience with use of mabthera (rituximab) in treatment of indolent non-Hodgkin's disease refractory to standard chemotherapy].
Korolenko VO; Gershanovich ML; Tikhonova VV
Vopr Onkol; 2004; 50(4):421-5. PubMed ID: 15605764
[No Abstract] [Full Text] [Related]
39. [Primary gastric lymphoma in an HIV positive patient].
Sebastián JJ; Fuentes J; García S; Uribarrena R; Yus C; Boldova I
Rev Esp Enferm Dig; 1995 Oct; 87(10):731-4. PubMed ID: 8519540
[TBL] [Abstract][Full Text] [Related]
40. Management of multifocal primary cutaneous CD30 anaplastic large cell lymphoma.
Shehan JM; Kalaaji AN; Markovic SN; Ahmed I
J Am Acad Dermatol; 2004 Jul; 51(1):103-10. PubMed ID: 15243534
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]